7016 POSTER Second Line Chemotherapy After Docetaxel Among Symptomatic Castration-Resistant Prostate Cancer (CPRC) Patients – GETUG-P02 Randomized Phase II Trial
Joly, F., Delva, R., Mourey, L., Bompas, E., Allouache, N., Sevin, E., Vedrine, L., Ravaud, A., Noal, S., Oudard, S.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71967-0
Date:
September, 2011
File:
PDF, 43 KB
english, 2011